Literature DB >> 18606655

Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade.

Bert Verbinnen1, An D Billiau, Jan Vermeiren, Georgina Galicia, Dominique M A Bullens, Louis Boon, Pascal Cadot, Greet Hens, Christiane Dewolf-Peeters, Stefaan W Van Gool, Jan L Ceuppens.   

Abstract

Blocking of costimulatory signals for T cell activation leads to tolerance in several transplantation models, but the underlying mechanisms are incompletely understood. We analyzed the involvement of regulatory T cells (Treg) and deletion of alloreactive cells in the induction and maintenance of tolerance after costimulation blockade in a mouse model of graft-vs-host reaction. Injection of splenocytes from the C57BL/6 parent strain into a sublethally irradiated F(1) offspring (C57BL/6 x C3H) induced a GVHR characterized by severe pancytopenia. Treatment with anti-CD40L mAb and CTLA4-Ig every 3 days during 3 wk after splenocyte injection prevented disease development and induced a long-lasting state of stable mixed chimerism (>120 days). In parallel, host-specific tolerance was achieved as demonstrated by lack of host-directed alloreactivity of donor-type T cells in vitro and in vivo. Chimerism and tolerance were also obtained after CD25(+) cell-depleted splenocyte transfer, showing that CD25(+) natural Treg are not essential for tolerance induction. We further show that costimulation blockade results in enhanced Treg cell activity at early time points (days 6-30) after splenocyte transfer. This was demonstrated by the presence of a high percentage of Foxp3(+) cells among donor CD4(+) cells in the spleen of treated animals, and our finding that isolated donor-type T cells at an early time point (day 30) after splenocyte transfer displayed suppressive capacity in vitro. At later time points (>30 days after splenocyte transfer), clonal deletion of host-reactive T cells was found to be a major mechanism responsible for tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606655     DOI: 10.4049/jimmunol.181.2.1034

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells.

Authors:  W H Kitchens; D Haridas; M E Wagener; M Song; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2011-09-22       Impact factor: 8.086

2.  Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients.

Authors:  Paolo Cravedi; Miguel Fribourg; Weijia Zhang; Zhengzi Yi; Elena Zaslavsky; German Nudelman; Lisa Anderson; Susan Hartzell; Sophie Brouard; Peter S Heeger
Journal:  Am J Transplant       Date:  2020-05-27       Impact factor: 8.086

3.  CD154 blockade abrogates allospecific responses and enhances CD4(+) regulatory T-cells in mouse orthotopic lung transplant.

Authors:  J M Dodd-o; E A Lendermon; H L Miller; Q Zhong; E R John; W M Jungraithmayr; F R D'Alessio; J F McDyer
Journal:  Am J Transplant       Date:  2011-08-09       Impact factor: 8.086

4.  Hyperlipidemia Alters Regulatory T Cell Function and Promotes Resistance to Tolerance Induction Through Costimulatory Molecule Blockade.

Authors:  J Bagley; J Yuan; A Chandrakar; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

5.  Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure.

Authors:  B E Burrell; J S Bromberg
Journal:  Am J Transplant       Date:  2011-12-17       Impact factor: 8.086

6.  The role of IL-6 in hyperlipidemia-induced accelerated rejection.

Authors:  Linus Williams; Jessamyn Bagley; John Iacomini
Journal:  Am J Transplant       Date:  2021-10-12       Impact factor: 8.086

7.  Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling.

Authors:  Horng-Ren Yang; Hong-Shuie Chou; Xiaodong Gu; Lianfu Wang; Kathleen E Brown; John J Fung; Lina Lu; Shiguang Qian
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

Review 8.  Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells.

Authors:  Alwi Shatry; Jackeline Chirinos; Michael A Gorin; Monica Jones; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2009-08-03       Impact factor: 5.742

9.  An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans.

Authors:  James M Kelley; Laura B Hughes; Jeffrey D Faggard; Maria I Danila; Monica H Crawford; Yuanqing Edberg; Miguel A Padilla; Hemant K Tiwari; Andrew O Westfall; Graciela S Alarcón; Doyt L Conn; Beth L Jonas; Leigh F Callahan; Edwin A Smith; Richard D Brasington; David B Allison; Robert P Kimberly; Larry W Moreland; Jeffrey C Edberg; S Louis Bridges
Journal:  PLoS Genet       Date:  2009-03-20       Impact factor: 5.917

10.  T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice.

Authors:  Vince N Montes; Michael S Turner; Savitha Subramanian; Yilei Ding; Martha Hayden-Ledbetter; Sonya Slater; Leela Goodspeed; Shari Wang; Mohamed Omer; Laura J Den Hartigh; Michelle M Averill; Kevin D O'Brien; Jeffrey Ledbetter; Alan Chait
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.